Clinical trials are most successful when the participants ... it now plays a central role in bridging the gap between research and clinical application. The importance of biosimilars only ...

has granted Clinical Trial Application (CTA) approval for the first-in-human Phase I/IIa clinical trial of ITOP1, the company's lead 'off-the-shelf' cancer vaccine. ITOP1 is a precision cancer ...

Australia also utilises the Clinical Trial Exemption (CTX) scheme. The CTX scheme involves the sponsors submitting an application to conduct one or more clinical trials with a particular ...

Cullinan Therapeutics, Inc., a biopharmaceutical company focused on developing modality-agnostic targeted therapies, announced that the European Medicines Agency (EMA) approved the company’s Clinical ...

has approved the Clinical Trial Application (CTA) for IOMX-0675, a LILRB1/LILRB2 cross-specific antibody designed to reverse immune suppression in solid tumors. The phase I/IIa clinical trial will ...

Lynae Darbes, PhD, discusses what her research results mean when it comes to implementation of self-testing and counselling ...

The first-ever analysis of the UK clinical trial landscape by the Medicines and Healthcare products Regulatory Agency (MHRA) and the University of Liverpool reveals the UK is a global leader in ...